Matches in Nanopublications for { ?s ?p "[Our results demonstrate that loss of SPR1 expression in breast tumor cells results from impaired transactivation through the AP-1 site in the SPR1 promoter, as well as from the presence of a negative regulatory element active in both normal and tumor cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- assertion description "[Our results demonstrate that loss of SPR1 expression in breast tumor cells results from impaired transactivation through the AP-1 site in the SPR1 promoter, as well as from the presence of a negative regulatory element active in both normal and tumor cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP978290.RAECwMD7aIqHoBwTOWEPP_B2ufUmldEdcYILr38ODBzdg130_assertion description "[Our results demonstrate that loss of SPR1 expression in breast tumor cells results from impaired transactivation through the AP-1 site in the SPR1 promoter, as well as from the presence of a negative regulatory element active in both normal and tumor cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP978290.RAECwMD7aIqHoBwTOWEPP_B2ufUmldEdcYILr38ODBzdg130_provenance.
- NP264211.RAN3MpD9ytOcKQ0oJkt2RiyACwnEuEJ2jwy57BqM2xFak130_assertion description "[Our results demonstrate that loss of SPR1 expression in breast tumor cells results from impaired transactivation through the AP-1 site in the SPR1 promoter, as well as from the presence of a negative regulatory element active in both normal and tumor cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP264211.RAN3MpD9ytOcKQ0oJkt2RiyACwnEuEJ2jwy57BqM2xFak130_provenance.